Free US stock correlation to major indices and sector benchmarks for performance attribution analysis. We help you understand how your portfolio moves relative to broader market benchmarks.
As of 2026-04-20, United Therapeutics Corporation (UTHR) trades at a current price of $573.44, marking a 2.54% decline in recent trading. This analysis explores key technical levels for UTHR, prevailing market context for the biotech sector, and potential short-term price scenarios for the stock, without providing any investment recommendations. Recent price action for UTHR has been largely range-bound, with traders focusing on two key price points that have acted as consistent barriers to both
United (UTHR) Stock Delisting (Risk Aversion) 2026-04-20 - Open Stock Signal Network
UTHR - Stock Analysis
3420 Comments
1138 Likes
1
Senua
Influential Reader
2 hours ago
Real-time US stock institutional ownership tracking and fund flow analysis to understand who owns and is buying specific stocks in the market. We monitor 13F filings and institutional buying patterns because large investors often have superior information and research capabilities. We provide ownership data, fund flow analysis, and institutional positioning for comprehensive coverage. Follow institutional money with our comprehensive ownership tracking and analysis tools for smarter investment decisions.
👍 182
Reply
2
Breonte
Active Contributor
5 hours ago
I read this and now I’m reconsidering everything.
👍 229
Reply
3
Miha
Legendary User
1 day ago
This feels like a signal.
👍 266
Reply
4
Jace
Power User
1 day ago
The market remains above key moving averages, indicating stability.
👍 13
Reply
5
Amerigo
Returning User
2 days ago
Really wish I had seen this sooner.
👍 194
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.